These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1329623)

  • 1. Increased sensitivity of Candida albicans cells accumulating 14 alpha-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents.
    Shimokawa O; Nakayama H
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1626-9. PubMed ID: 1329623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity.
    Rogers KM; Pierson CA; Culbertson NT; Mo C; Sturm AM; Eckstein J; Barbuch R; Lees ND; Bard M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3425-35. PubMed ID: 15328107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased drug sensitivity in Candida albicans cells accumulating 14-methylated sterols.
    Shimokawa O; Kato Y; Nakayama H
    J Med Vet Mycol; 1986 Dec; 24(6):481-3. PubMed ID: 3553523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
    Henry KW; Cruz MC; Katiyar SK; Edlind TD
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two natural molecules preferentially inhibit azole-resistant Candida albicans with MDR1 hyperactivation.
    Shi HZ; Chang WQ; Zhang M; Lou HX
    Chin J Nat Med; 2019 Mar; 17(3):209-217. PubMed ID: 30910057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced production of farnesol by Candida albicans treated with four azoles.
    Hornby JM; Nickerson KW
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2305-7. PubMed ID: 15155241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals.
    Luna-Tapia A; Kerns ME; Eberle KE; Jursic BS; Palmer GE
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2410-20. PubMed ID: 25666149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn.
    Lv QZ; Yan L; Jiang YY
    Virulence; 2016 Aug; 7(6):649-59. PubMed ID: 27221657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergism between nyasol, an active compound isolated from Anemarrhena asphodeloides, and azole agents against Candida albicans.
    Iida Y; Oh KB; Saito M; Matsuoka H; Kurata H
    Planta Med; 2000 Jun; 66(5):435-8. PubMed ID: 10909263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.
    Marichal P; Gorrens J; Laurijssens L; Vermuyten K; Van Hove C; Le Jeune L; Verhasselt P; Sanglard D; Borgers M; Ramaekers FC; Odds F; Vanden Bossche H
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2663-70. PubMed ID: 10543744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.
    Lees ND; Broughton MC; Sanglard D; Bard M
    Antimicrob Agents Chemother; 1990 May; 34(5):831-6. PubMed ID: 2193620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of C-5 Sterol Desaturase Activity in
    Luna-Tapia A; Butts A; Palmer GE
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
    Onyewu C; Blankenship JR; Del Poeta M; Heitman J
    Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis.
    Heimark L; Shipkova P; Greene J; Munayyer H; Yarosh-Tomaine T; DiDomenico B; Hare R; Pramanik BN
    J Mass Spectrom; 2002 Mar; 37(3):265-9. PubMed ID: 11921367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL; Edlind TD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.